Thomas Schoetzau

Q: What is Thomas Schoetzau email address?

Email Thomas Schoetzau at tschoetzau@web.de and thomas.schoetzau@bayer.com. This email is the most updated Thomas Schoetzau's email found in 2026.

Q: How to contact Thomas Schoetzau?

To contact Thomas Schoetzau send an email to tschoetzau@web.de or thomas.schoetzau@bayer.com. (updated on March 07, 2025)

QA Manager Combination Product at Bayer Pharmaceuticals | Greater Erfurt Area

About Thomas Schoetzau

Thomas Schoetzau currently serves as the QA Manager for Combination Products at Bayer Pharmaceuticals, where he plays a pivotal role in ensuring the quality, safety, and regulatory compliance of innovative respiratory therapies. With extensive experience in the development of respiratory products, Thomas possesses a deep understanding of the complexities involved in designing and manufacturing combination products, particularly Dry Powder Inhalers (DPIs). His expertise encompasses the entire lifecycle of these products—from initial research and development to validation, tech transfer, and commercial launch—making him a key driver in Bayer’s portfolio of inhalation therapies.

In his current role, Thomas leads critical projects related to the design transfer and launch of new combination products, overseeing the meticulous maintenance of Design History Files (DHF) and Risk Management Files (RMF). His responsibilities include conducting impact assessments for global regulations and standards, ensuring that Bayer’s products meet evolving compliance requirements across different markets. His proficiency in Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and validation processes ensures that manufacturing processes are robust, compliant, and capable of delivering high-quality medical devices and combination products.

Thomas’s skill set also includes expertise in design control, risk management, and research & development, which enables him to effectively navigate the regulatory landscape and implement best practices in quality assurance. His background in biotechnology and inhalation device development positions him as a strategic leader in advancing Bayer’s innovative respiratory solutions, ensuring they meet stringent industry standards and patient needs worldwide.

Thomas Schoetzau Work